Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22218| Title: | Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options. | Austin Authors: | Schmidt, Andrew ;Azad, Arun;Goh, Jeffrey;Harris, Carole;Joshua, Anthony M;Weickhardt, Andrew;Krieger, Laurence | Affiliation: | Liz Plummer Cancer Centre, Cairns, Queensland, Australia Peter McCallum Cancer Centre, Melbourne, Victoria, Australia Royal Brisbane and Women's Hospital, Butterfield Street, Herston & University of Queensland, St Lucia, Queensland, Australia St George Hospital and Sutherland Clinical School UNSW, Kogarah, New South Wales, Australia The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Royal North Shore Hospital, Reserve Rd, St Leonards, Northern Cancer Institute, St. Leonards, New South Wales, Australia |
Issue Date: | Nov-2019 | Publication information: | Asia-Pacific journal of clinical oncology 2019; 15 Suppl 10: 3-10 | Abstract: | Vascular endothelial growth factor receptor tyrosine kinase inhibitors have provided an effective standard of care for the treatment of metastatic clear cell renal cell carcinoma (mRCC). Survival is prolonged with emergence of modern immuno-oncology combination regimens. Prognostic risk assessment is essential for choosing between these therapies to determine the most appropriate first line treatment option, with selection based on International Metastatic RCC Database Consortium Risk Category. We review the current subsidized first line treatments for mRCC in Australia and consider the evidence for treatment selection and sequencing. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/22218 | DOI: | 10.1111/ajco.13289 | Journal: | Asia-Pacific journal of clinical oncology | PubMed URL: | 31762165 | Type: | Journal Article | Subjects: | VEGF tyrosine kinase inhibitors immuno-oncology renal cell carcinoma |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.